Moderna, Merck breakthrough could usher in cancer vaccines

Moderna and Merck have achieved a significant breakthrough in the development of cancer vaccines. According to the companies, their new vaccine successfully helped prevent the return and spread of melanoma. This result was observed during a clinical trial that involved more than 1,000 patients. This advancement could usher in a new era of cancer vaccines, providing a critical tool in the fight against melanoma by reducing recurrence and metastasis in a large patient group.